Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

William H. Rastetter

At a glance: William H. Rastetter is Director at Dare Bioscience (DARE). Their latest SEC Form 4, filed Nov 20, 2026, reported a sale of $382. On file: 0 purchase lines ($0) and 2 sale lines ($2.7M).

Director at Dare Bioscience, Inc. (DARE); Director at Neurocrine Biosciences Inc (NBIX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.7M

William H. Rastetter's InsiderPrint

2 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of William H. Rastetter: 2 trades, 2025 to 20262025: 0 buys, 1 sale2026: 0 buys, 1 sale
  • Bump outward: a purchase (0)
  • Dent inward: a sale (2)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 20 NewSEC DAREDare Bioscience, Inc. Sell 859 $0.45 $382 —
Nov 6SEC NBIXNeurocrine Biosciences Inc Sell Plan 18,00040,360 held (−31%) $151.82 $2.7M +3.6%
  • Sell

    Director William H Rastetter sold $2.7M of NBIX at $151.82 — cuts the stake by 31%; pre-scheduled 10b5-1 plan sale.

Follow William H. Rastetter

Get one email when William H. Rastetter files a new purchase or sale. Free.

At most one email a day about William H. Rastetter, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.